Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
isperse
Press Release
Jun 6, 2016
Pulmatrix's CEO Eyes $25 Billion COPD Market for Its Inhaled Drug Delivery Technology
In an Interview With Stock-Sector, Dr. Clarke Explains How Pulmatrix Is Targeting Major Markets With the iSPERSE Technology Platform That Delivers Drugs to the Lungs More Efficiently
Read More
First
Prev
1
Next
Last
